Barclays
KMTS icon

Barclays’s Kestra Medical Technologies KMTS Stock Holding History

Barclays’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.62M Buy
57,396
+47,644
+489% +$1.21M ﹤0.01% 2732
2026
Q2 		$248K Sell
9,752
-7,431
-43% -$156K ﹤0.01% 3583
2026
Q1 		$342K Sell
17,183
-23,987
-58% -$565K ﹤0.01% 3397
2025
Q4 		$1.09M Buy
41,170
+22,507
+121% +$580K ﹤0.01% 3368
2025
Q3 		$443K Sell
18,663
-10,796
-37% -$193K ﹤0.01% 3886
2025
Q2 		$488K Buy
29,459
+21,459
+268% +$468K ﹤0.01% 3769
2025
Q1 		$199K Buy
+8,000
New +$184K ﹤0.01% 4038

Other funds holding KMTS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Andera Partners
Andera Partners Paris $176M AUM 1.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $189B AUM 37.1% 1-Year Est. Return

Barclays's KMTS Position: Q3 2026 in Review

Barclays increased its Kestra Medical Technologies (KMTS) stake by 489% in Q3 2026, buying an estimated $1.21M and bringing the position to 57,396 shares worth $1.62M. The position accounts for ﹤0.01% of the portfolio, ranked #2732.

Barclays first reported a position in KMTS in Q1 2025 and has held it in 7 quarters since. 46 funds tracked by Wall St. Rank hold KMTS as of Q3 2026.

  • Barclays held 57,396 shares of Kestra Medical Technologies worth $1.62M as of Q3 2026.
  • Barclays bought 47,644 Kestra Medical Technologies shares in Q3 2026, an estimated $1.21M.
  • Kestra Medical Technologies made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #2732 holding.
  • Barclays first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 7 quarters since.
  • 46 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.